Preparation, in vitro and in vivo evaluation of 99mTc-Annexin B1: A novel radioligand for apoptosis imaging
- 1 October 2005
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 335 (4) , 1102-1106
- https://doi.org/10.1016/j.bbrc.2005.07.188
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- The role of coordination chemistry in the development of target-specific radiopharmaceuticalsChemical Society Reviews, 2004
- Apoptosis: mechanisms and clinical implicationsAnaesthesia, 2000
- Apoptosis in cancerCarcinogenesis: Integrative Cancer Research, 2000
- Technetium-99m HYNIC-annexin V: a potential radiopharmaceutical for the in-vivo detection of apoptosisEuropean Journal of Nuclear Medicine and Molecular Imaging, 1999
- Apoptosis: a potential target for discovering novel therapies for cardiovascular diseasesCurrent Opinion in Chemical Biology, 1999
- Apoptosis in the Pathogenesis and Treatment of DiseaseScience, 1995
- Evaluation of annexin V as a platelet-directed thrombus targeting agentThrombosis Research, 1994
- Apoptosis. Its significance in cancer and cancer TherapyCancer, 1994
- Lethal effect of the anti-Fas antibody in miceNature, 1993
- A rapid chemical method of labeling human plasma proteins with 99mTc-pertechnetate at pH 7.4The International Journal of Applied Radiation and Isotopes, 1978